We are delighted to announce that the University of Bristol Enterprise Fund I, managed by Parkwalk, has invested in Azul Optics.

Azul Optics is developing a device that can rapidly assess macular pigment density. The device will be affordable, fast, easy-to-use and compact, making it easy to integrate macular pigment density screening into regular eye exams. The company’s goal is to introduce a technology that enables eye health professionals to rapidly assess macular pigments as an indicator of eye health.